ArticleOncology letters2015

Efficacy of TCH/TEC neoadjuvant chemotherapy for the treatment of HER-2-overexpressing breast cancer.

Weicai Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.